4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-21-118363
SVP, Chief Business Officer sold 32,960 shares at an average $4.97 ($163,866)
- SVP, Chief Business Officer acquired 27,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Korbel Gregory Alan · SVP, Chief Business Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-20 | Sale : show line 1 in the form | −5,460 | $4.98 | $27,191 | 17,167 | D |
| 2021-09-20 | Exercise or conversion : show line 2 in the form | +27,500 | $0.92 | $25,300 | 44,667 | D |
| 2021-09-20 | Sale : show line 3 in the form | −27,500 | $4.97 | $136,675 | 17,167 | D |
| Open-market sales · 32,960 sh · avg $4.97 · $163,866 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-20 | Exercise or conversion : show line 4 in the form Stock Option (right to Buy) | −27,500 | 52,745 | D |
Loading xslF345X03/tm2127534-4_4seq1.xml…